| Type | Description |
|---|---|
| Definition | PRA1 domain family member 2 |
| Date | Results | Publications |
|---|---|---|
| 2019-11-30 10:54:00 | PRAF2 could be used as a potential prognostic biomarker and represent a potential therapeutic target for ESCC. | 31200670 |
| 2013-08-31 12:36:00 | PRAF2 plays an essential role in neuroblastoma tumorigenesis and metastasis. | 23440329 |
| 2011-07-09 11:09:00 | Praf2 is a novel Bcl-xL/Bcl-2 interacting protein with the ability to modulate survival of cancer cells | 21203533 |
| 2010-08-16 11:47:00 | PRAF2 expression is elevated in various tumors with exceptionally high expression in malignant gliomas, and may thus presents a candidate molecular target for therapeutic intervention. | 20412121 |
| 2010-01-21 00:00:00 | PRAF2 has a role in progression of neuroblastoma | 17975142 |
| Type | IDs |
|---|---|
| Synonymous | JM4, Yip6a |
| Gene |
UniProtKB-ID:
PRAF2_HUMAN,
A0A024QZ22_HUMAN
UniprotKB:
O60831,
A0A024QZ22
UniParc:
UPI000004A126
EMBL:
CR457023,
BC021213,
CH471224,
AK315374,
AJ005896
Ensembl:
ENSG00000243279
KO:
hsa:11230
|
| Nucleutide sequences |
EMBL-CDS:
BAG37767.1,
CAG33304.1,
CAA06753.1,
EAW50706.1,
AAH21213.1,
EAW50707.1
Gene_ORFName:
JM4,
hCG_19825
Ensembl_TRS:
ENST00000553851
|
| Protein sequencees |
Ensembl_PRO:
ENSP00000451962
RefSeq:
NP_009144.1
|
| Others |
UniRef100:
UniRef100_O60831
UniRef90:
UniRef90_O60831
UniRef50:
UniRef50_O60831
UniGene:
Hs.29595
CCDS:
CCDS14317.1
|
| {{proteinIndex+1}} | mRNA | Protein | UniprotKB | Description | ||||
|---|---|---|---|---|---|---|---|---|
| Refseq |
{{protein.nucleotideVersion}}
Ensembl: {{protein.nucleotideEnsembl}} |
{{protein.proteinVersion}}
Ensembl: {{protein.proteinEnsembl}} |
{{uniprot}} , |
Definition: {{{protein.definition}}}Transcript Veriant:{{protein.transcriptVeriant}} Status: {{protein.status}} |
||||
| Location | {{protein.contigId}} ( {{protein.positionStart}}..{{protein.positionEnd}} , {{protein.orientation}} ) | |||||||
| Conserved domain | Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
||||
暂无数据
| 排名 | 科研单位 | 文献 |
|---|---|---|
| {{affIndex+1}} |
{{aff.value}} |
{{aff.size}} |
目前还没有研究热点单位
| 排名 | 研究人员 | 文献 |
|---|---|---|
| {{authorIndex+1}} |
{{author.value}} |
{{author.size}} |
目前还没有研究热点人员